Circulating cytokines in sickle cell patients during steady state

Area of Science:

• Hematology
• Immunology
• Molecular Biology

Background:

• Sickle cell disease (SSD) is a genetic blood disorder.
• Fetal hemoglobin (HbF) levels influence SSD severity.
• Cytokine dysregulation may play a role in SSD pathophysiology.

Purpose of the Study:

• To investigate plasma levels of key cytokines in steady-state sickle cell patients.
• To determine the correlation between cytokine levels and fetal hemoglobin (HbF) levels.
• To explore the role of cytokines in regulating erythroid progenitor cells in SSD.

Main Methods:

• Plasma samples were collected from steady-state sickle cell patients and normal controls.
• Levels of granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), IL-6, and IL-1 (alpha,beta) were measured.
• Patients were categorized into low HbF (LFSS) and high HbF (HFSS) groups.

Main Results:

• LFSS patients exhibited elevated plasma GM-CSF; GM-CSF was undetectable in HFSS patients.
• HFSS patients showed increased plasma IL-3, while LFSS patients had lower or undetectable IL-3.
• IL-1 and IL-6 were detected in some SSD patients, but without correlation to HbF levels.
• Normal controls were negative for all cytokines except one positive for IL-3.

Conclusions:

• Haemopoietic stress level may dictate the involvement of GM-CSF or IL-3 in regulating circulating BFU-E in SSD.
• Distinct cytokine profiles are associated with different HbF levels in SSD.
• These findings contribute to understanding the molecular mechanisms underlying SSD pathophysiology.